Intronn
1988
FOUNDED
M&A
STATUS
11-20
EMPLOYEES
M&A
LATEST DEAL TYPE
5
FINANCING ROUNDS
Description
Developer of spliceosome-mediated RNA trans-splicing (SMaRT) technology. The company has produced a series of PTMs capable of base-pairing to and trans-splicing with disease associated pre-mRNA targets.
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Acquirer
Virxsys
Primary Office
- 910 Clopper Road
- South Building, Suite 210
- Gaithersburg, MD 20878
- United States
+1 (240) 000-0000
Intronn Valuation and Funding
| Deal Type | Date | Amount | Post-Val | Valuation/ EBITDA |
Debt | Status |
|---|
This information is reserved for PitchBook Platform users. To explore Intronn‘s full profile, request access.
Request full access to PitchBookIntronn Former Investors
| Investor Name | Investor Type | Holding | Participating Rounds | Investor Since | Board Seat | Contact Info |
|---|
This information is reserved for PitchBook Platform users. To explore Intronn‘s full profile, request access.
Request full access to PitchBook